SENSEX
NIFTY
GOLD
USD/INR

Weather

image 19    C

Markets News

News

Markets / The Economic Times

details

US FDA review boosts odds for Wockhardts NCE success story: Vishal Manchanda

Wockhardts breakthrough respiratory drug Zaynich moves a step closer to market as the US FDA accepts it for review, boosting approval odds and keeping the company on track for its mid-2026 launch target. Equity analyst Vishal Manchanda says the priority review points to a likely early-FY27 approval, even as markets react sharply and other India-focused pipeline drugs await clarity.

2 Dec 2025 9:11 am